Tirbanibulin
Tirbanibulin(KX2-391,KX 01), the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines. Phase 2.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | S2700 |
| Sku # | S2700-5mg |
| Pricing | 5mg, $90.00 |